Skip to content

Clinical trials

Fatty Liver trials in Czechia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Fatty Liver Country / region: Czechia Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20171
20181
20201
20212
20221
20231
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Recruiting3
Active, not recruiting2
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
General University Hospital, Prague2
89bio, Inc.1
Eli Lilly and Company1
Faculty Hospital Kralovske Vinohrady1
Inventiva Pharma1
Julius Clinical1
Novartis Pharmaceuticals1
University Hospital Ostrava1
University of Ostrava1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Fatty Liver10
Non-alcoholic Fatty Liver Disease7
Liver Cirrhosis6
Obesity3
Digestive System Diseases2
Fibrosis2
Liver Diseases2
Diabetes Mellitus1
Diabetes Mellitus, Type 21
Hypertension1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.